NursingHumansPain Management
Suzetrigine for pain relief: Key considerations for nurses.
Hanna Reker, Dan Sheridan
Published: 202510.1097/NSG.0000000000000266
Abstract
ABSTRACT: Suzetrigine (JOURNAVX) is a novel oral medication approved in January 2025 for the treatment of moderate-to-severe acute pain in adults. It works by selectively inhibiting NaV1.8 voltage-gated sodium channels, which play a key role in pain…
Preview only. Read the full abstract at the source